Trademarks
ALLTRANZ
- Serial number
- 85599967
- Registration number
- 4564661
- Filed
- 2012-04-17
- Registered
- 2014-07-08
- Status
- Registration cancelled 2021-02-12 (USPTO status code 710, 2021-02-12; as of the dataset)
- Classes
- 001, 005, 042
- Elsewhere
- USPTO TSDR record (current status) ↗
- Source
- TRCFECO2, file of 2024-03-27
Goods and services
Chemicals for use in the manufacture of pharmaceuticals | Pharmaceutical preparations, both prescription and over-the-counter, for human and animal use, namely, analgesics, anti-inflammatories, antiarthritic preparations, preparations for treating nausea and vertigo, preparations for the relief of pain and skin irritations, pharmaceutical preparations for enhancing topical penetration of drug delivery through the skin and mucous membranes; tranquilizers and psychotropics; medicated skin care preparations, namely, medicated skin creams, gels, antibiotic ointments and lotions for human and animal use; cleansing solutions for medical use, transdermal patches for use in the treatment of alcoholism, Alzheimer's disease, anorexia, anxiety disorders, appetite modulation, arthritis, cachexia, depression, drug addiction, inflammation, multiple sclerosis, neuralgia, neuropathic pain, obesity, opiate dependence, osteo-arthritis, pain, postsurgical pain, postherpetic neuralgia, seizure disorders, sleep disorders, and cerebrovascular disease; pharmaceutical preparations for the treatment of pain, substance addiction, substance abuse, muscle spasms, treatment of alcoholism, and treatment of neurodegeneration; veterinary products, namely, topical medicated treatments, namely, ointments, creams, solutions, gels, patches, poultices, and plasters for use in the relief of inflammation, arthritis, muscle spasms, pain, dermatitis and skin irritations; veterinary products, namely, pharmaceutical preparations for treating nausea and vertigo, cleansing solutions for medical use, transdermal patches for use in the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease; veterinary dermal and transdermal devices, namely, microneedles sold filled with medication for the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease, and for use in the relief of inflammation, arthritis, muscle spasms, pain, osteoarthritis pain, dermatitis and skin inflammation | Pharmaceutical research and development services
Owners
| Owner | Role | Entity | Place | Also on furp.org | Source |
|---|---|---|---|---|---|
| Alltranz Inc. | Original applicant, Owner at publication, Original registrant | Corporation | Lexington, KY | TRCFECO2, file of 2024-03-27 | |
| ZYNERBA PHARMACEUTICALS, INC. | New owner after registration | Corporation | DEVON, PA | ZYNERBA PHARMACEUTICALS, INC. Federal lobbying client EXACT high confidence: identical full name and state | TRCFECO2, file of 2024-03-27 |
Assignment history
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2017-11-20 | Name change Change of name | ALLTRANZ INC. | ZYNERBA PHARMACEUTICALS, INC. DEVON, PA | 6209/162 | TRASECO, file of 2026-09-29 |
USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.